Abstract

Genetic factors play a role in the risk of idiopathic pulmonary fibrosis (IPF). Specifically, MUC5B rs35705950 non-risk alleles and immunologic aberrations were associated with the IPF’s progression. However, rare genetic variants have not been systematically investigated in Chinese IPF patients. In this study, we aimed to improve understanding of the genetic architecture of IPF in the Chinese population and to assess whether rare protein-coding variants in the immunity pathway genes are enriched in the IPF patients with non-risk alleles at rs35705950. A case–control exome-wide study including 110 IPF patients and 60 matched healthy controls was conducted. rs35705950 was genotyped by Sanger sequencing. To identify genes enriched in IPF, gene-based association analyses were performed. Identified genes were included for further pathway analyses using gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG). Associations between rs35705950 and genes enriched in the immunity pathway were also tested. 226 genes that were enriched with deleterious variants were identified in IPF patients. Out of them, 36 genes were significantly enriched in GO and KEGG pathways in the IPF. Pathway analyses implicated that these genes were involved in the immune response and cell adhesion. Rare protein-altering variants in genes related to the immunity pathway did not significantly differ between patients with a MUC5B risk allele and individuals without risk allele. We drafted a comprehensive mutational landscape of rare protein-coding variants in the Chinese IPF and identified genes related to immune response and cell adhesion. These results partially explain changes in gene expression involved in the immunity/inflammatory pathways in IPF patients.

Highlights

  • Genetic factors play a role in the risk of idiopathic pulmonary fibrosis (IPF)

  • A single nucleotide polymorphism (SNP) rs35705950 in the promoter region of the MUC5B gene demonstrated to be strongly associated with the IPF and familial interstitial pneumonia (FIP) in one genome-wide linkage a­ nalysis[9] and the association was validated in multiple different ­cohorts[10,11,12,13,14,15,16]

  • The above HLA genes were included in the subsequent analysis (GO and Kyoto Encyclopedia of Genes and Genomes (KEGG)), because the objective of this study was to find genes and pathways that might be related to IPF in a more conservative way, and to avoid missing genes potentially associated with the IPF

Read more

Summary

Introduction

Genetic factors play a role in the risk of idiopathic pulmonary fibrosis (IPF). MUC5B rs35705950 non-risk alleles and immunologic aberrations were associated with the IPF’s progression. We aimed to improve understanding of the genetic architecture of IPF in the Chinese population and to assess whether rare protein-coding variants in the immunity pathway genes are enriched in the IPF patients with non-risk alleles at rs35705950. We drafted a comprehensive mutational landscape of rare proteincoding variants in the Chinese IPF and identified genes related to immune response and cell adhesion. These results partially explain changes in gene expression involved in the immunity/inflammatory pathways in IPF patients. Two genes involved in encoding surfactant proteins A and C (SFTPA2 and SFTPC) have been related to the IPF in sporadic ­studies[29,30] These risk variants generally explain a relatively small proportion of IPF’s heritability; except for rs35705950

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.